Physician profile
Alexander Rosenstein
NPI 1063513554
$44,903.77
in general payments reported to CMS, 2019-2025
9 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,305 · 2021: $1,598 · 2024: $20K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $17K · Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,650.00 |
| Travel and Lodging | $17,216.86 |
| Food and Beverage | $133.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovative Medical Products, INC. | $37,960.66 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $4,300.08 | 2019-2021 | |
| Medtronic, INC. | $1,434.96 | 2021 | |
| Medical Device Business Services, INC. | $848.98 | 2019 | |
| Depuy Synthes Sales INC. | $132.47 | 2019-2024 | Matrixorthognathic |
| Team_makena_llc | $105.31 | 2019 | |
| Boston Scientific Corporation | $72.96 | 2019 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Bioventus LLC | $18.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Rosenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.